HARVARD BIOSCIENCE INC
HBIONext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for HBIO. That does not mean none is planned.
Get an email about HBIO's next catalysts
Track HARVARD BIOSCIENCE (HBIO) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
HBIO Earnings Report
FQ end Sep/2026 | Call: bmo
Market Overview
Stock performance and key metrics
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO. Headquartered in Holliston, Massachusetts, United States, the company's brands include: Biochrom, BTX, CMA, Data Sciences International (DSI), Harvard Apparatus, HEKA, Hugo Sachs Elektronik, KD Scientific, Multi Channel Systems (MCS), Panlab, and Warner Instruments. The company has approximately 355 employees, with 216 of those in the USA, and its principal manufacturing facilities are in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany.
WebsiteFrequently asked questions
What is in HARVARD BIOSCIENCE INC's drug pipeline?→
CatalystAlert tracks 2 drug candidates in HARVARD BIOSCIENCE INC's (HBIO) pipeline across Phase 3, Phase 2. Its lead program is Kaletra (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is HARVARD BIOSCIENCE INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for HARVARD BIOSCIENCE INC (HBIO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track HBIO biotech catalysts?→
Add HBIO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow HARVARD BIOSCIENCE INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.